44.89% of FOXO Technologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

FOXO Technologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/27/2023	Virtu Financial LLC	95,761	$30K	0.0%	N/A	0.206%
1/31/2023	Equitec Proprietary Markets LLC	136,996	$52K	0.0%	-37.0%	0.439%
11/14/2022	Powell Investment Advisors LLC	38,500	$49K	0.0%	N/A	0.230%

Data available starting January 2016

FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

Today's Range

Now: $0.30

$0.29

$0.30

50 Day Range

MA: $0.32

$0.27

$0.41

52 Week Range

Now: $0.30

$0.25

$5.28

Volume

15,296 shs

Average Volume

1,124,720 shs

Market Capitalization

$2.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.74

Who are the company insiders with the largest holdings of FOXO Technologies?: FOXO Technologies' top insider investors include:
Vincent J Dowling Jr (Major Shareholder)
Learn More about top insider investors at FOXO Technologies.